Arbor Biotechnologies nets $215m Series B

Arbor Biotechnologies, a biotechnology company, has raised $215 million in Series B financing.

Arbor Biotechnologies, a biotechnology company, has raised $215 million in Series B financing. Temasek, Ally Bridge Group, and TCG Crossover led the round.

Source: Press Release